









시장가
/
주식
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

54.900USD

-0.600-1.08%

종가 08/29, 16:00（ET）시세는 15분 지연됩니다

3.73B시가총액

14.68P/E TTM



Lantheus Holdings Inc

54.900

-0.600-1.08%

개요 회사 금융 분석

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. It classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus in cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, and others. Its pipeline includes B amyloid positron emission tomography (PET) imaging agent, NAV-4694, also known as F18-flutafuranol. It has pre-clinical assets, specifically the TROP2 and DUNP19.

회사 정보

종목 코드 LNTH

회사 이름Lantheus Holdings Inc

상장일Jun 25, 2015

CEOMr. Brian A. Markison

직원 수808

유형Ordinary Share

회계 연도 종료Jun 25

주소331 Treble Cove Road

도시NORTH BILLERICA

증권 거래소NASDAQ Global Market Consolidated

국가United States of America

우편 번호01862

전화19786718001

웹사이트https://www.lantheus.com/

종목 코드 LNTH

상장일Jun 25, 2015

CEOMr. Brian A. Markison

회사 임원

이름

이름/직위

직위

주식 보유

변동

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+34.47%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+450.62%

Mr. Samuel R. (Sam) Leno

Independent Director

Ms. Jamie Spaeth

Chief People Officer

이름

이름/직위

직위

주식 보유

변동

Ms. Mary Anne Heino

Chairman of the Board

584.72K

-4.27%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+35.31%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-31.55%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+7.64%

Ms. Julie H. Mchugh

Lead Independent Director

25.96K

-16.67%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+10.09%

수익 분석

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

데이터 없음

사업별

지역별

사업별USD

이름

수익

비율

PYLARIFY

257.65M

0.00%

DEFINITY

79.21M

0.00%

TechneLite

19.71M

0.00%

Strategic partnerships and other

10.75M

0.00%

Other precision diagnostics

5.44M

0.00%

Radiopharmaceutical oncology

0.00

0.00%

주식 보유 통계

마지막 업데이트: Fri, Aug 15

주주

주주 유형

주주

비율

BlackRock Institutional Trust Company, N.A.

11.03%

Janus Henderson Investors

10.21%

The Vanguard Group, Inc.

10.03%

Fidelity Management & Research Company LLC

6.08%

Farallon Capital Management, L.L.C.

4.88%

기타

57.78%

주주

비율

BlackRock Institutional Trust Company, N.A.

11.03%

Janus Henderson Investors

10.21%

The Vanguard Group, Inc.

10.03%

Fidelity Management & Research Company LLC

6.08%

Farallon Capital Management, L.L.C.

4.88%

기타

57.78%

주주 유형

주주

비율

Investment Advisor

57.48%

Investment Advisor/Hedge Fund

45.03%

Hedge Fund

6.89%

Research Firm

3.61%

Individual Investor

2.32%

Pension Fund

1.94%

Bank and Trust

1.50%

Sovereign Wealth Fund

0.74%

Venture Capital

0.11%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

1039

82.20M

120.88%

-4.84M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

2023Q2

790

72.85M

106.61%

-3.94M

2023Q1

733

71.94M

105.47%

-6.73M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

BlackRock Institutional Trust Company, N.A.

7.79M

11.27%

+17.69K

+0.23%

Mar 31, 2025

Janus Henderson Investors

6.26M

9.05%

-252.58K

-3.88%

May 30, 2025

The Vanguard Group, Inc.

6.99M

10.1%

-242.63K

-3.36%

Mar 31, 2025

Fidelity Management & Research Company LLC

2.17M

3.14%

+148.84K

+7.36%

Mar 31, 2025

Farallon Capital Management, L.L.C.

6.02M

8.71%

+707.00K

+13.30%

Mar 31, 2025

State Street Global Advisors (US)

2.64M

3.81%

-4.26K

-0.16%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.78M

2.57%

+94.57K

+5.62%

Mar 31, 2025

Wellington Management Company, LLP

909.10K

1.31%

+685.29K

+306.19%

Mar 31, 2025

Westfield Capital Management Company, L.P.

1.59M

2.3%

+34.05K

+2.19%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

1.41M

2.04%

-96.91K

-6.42%

Mar 31, 2025